Study Stopped
Low recruitment
The ACHIEVA Study of Enhanced Pharmacist Care on Antidepressant Use and Response
A COHORT AND INTERVENTION STUDY EVALUATING ANTIDEPRESSANT EPIDEMIOLOGY AND ADHERENCE: The ACHIEVA Study
1 other identifier
interventional
106
1 country
1
Brief Summary
This a comparative study of enhanced pharmacist care and regular care of patients starting on antidepressants. When providing participants with enhanced care pharmacists will use the Health Professional's Antidepressant Communications Tool (Health PACT) a minimum of three times during face-to-face discussions. This tool was developed specifically for this study. All participants will be followed for 26 weeks and will be assessed for duration of use of their antidepressant, adherence to treatment, and clinical response.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2006
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2006
CompletedFirst Submitted
Initial submission to the registry
July 24, 2006
CompletedFirst Posted
Study publicly available on registry
July 26, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2008
CompletedApril 11, 2022
May 1, 2008
July 24, 2006
April 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Persistence
Secondary Outcomes (4)
Adherence (mean possession ratio)
Beck Depression Inventory symptom improvement
Beck Anxiety Inventory symptom improvement
Change in antidepressant compliance questionnaire responses
Interventions
Eligibility Criteria
You may qualify if:
- patient presents to a pharmacy with a prescription for an antidepressant from a family physician
- patient with DSM-IV major or minor depression
- patient has not taken an antidepressant in the preceding six months
- patient is 18 years of age or older
- patient is fluent in English
- patient taking newly-prescribed antidepressant for no more than 1 week
You may not qualify if:
- patient with plans of leaving the vicinity within 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Albertalead
- Institute of Health Economics, Canadacollaborator
- Dalhousie Universitycollaborator
Study Sites (1)
EPICORE Centre
Edmonton, Alberta, T6G 2C8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David M Gardner, PharmD
Dalhousie University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 24, 2006
First Posted
July 26, 2006
Study Start
July 1, 2006
Study Completion
May 1, 2008
Last Updated
April 11, 2022
Record last verified: 2008-05